MIS416
MIS416
MIS416 (/mɪs fɔːr wʌn sɪks/), is a novel immunomodulatory compound that is currently being studied for its potential therapeutic applications in the treatment of various neurodegenerative diseases, including multiple sclerosis and Alzheimer's disease.
Etymology
The term "MIS416" is derived from the initials of the company that developed it, Micro Immunology Series, and the number 416, which is the specific identifier for this compound in the series.
Mechanism of Action
MIS416 acts by stimulating the body's innate immune system, specifically the myeloid cells. This leads to the production of various cytokines and chemokines, which play a crucial role in the body's immune response.
Clinical Trials
Several clinical trials have been conducted to evaluate the safety and efficacy of MIS416 in patients with multiple sclerosis. The results have shown promising potential for the use of this compound in the treatment of this disease.
Related Terms
- Immunomodulatory
- Neurodegenerative diseases
- Multiple sclerosis
- Alzheimer's disease
- Innate immune system
- Myeloid cells
- Cytokines
- Chemokines
- Clinical trials
External links
- Medical encyclopedia article on MIS416
- Wikipedia's article - MIS416
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski